• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CYP 0.00% 21.0¢

CYNATA THERAPEUTICS LIMITED - Charts / Financials

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and... Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.More

refresh Created with Sketch. REFRESH
Last update - 16.20pm 26/04/2024 (20 minute delay) ?
Day
Open 20.0¢   Day High 21.0¢   Day Low 20.0¢
Daily Volume 20743
Bids   Sellers
Number Price Volume   Number Price Volume
1 20.0¢ 20000   3 21.0¢ 54635

Directors & Senior Management

Dr. Kilian Kelly Chief Executive Officer, Managing Director, Director
Dr. Suzanne Lipe Vice President - Partner Engagement
Dr. Jolanta Airey Chief Medical Officer
Dr. Mathias Kroll Chief Business Officer
Mr. Peter Gordon Webse Company Secretary
Dr. Geoffrey E. D. Brooke Independent Non-Executive Chairman of the Board
Ms. Janine Rolfe Director
Dr. Darryl Maher Non-Executive Independent Director
Dr. Paul K. Wotton Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
21.0¢
Change
0.000(0.00%)
Mkt cap ! $37.72M
Open High Low Value Volume
20.0¢ 21.0¢ 20.0¢ $4.156K 20.74K

Buyers (Bids)

No. Vol. Price($)
1 20000 20.0¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 54635 3
View Market Depth
Last trade - 15.43pm 26/04/2024 (20 minute delay) ?
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.